![Mark Gilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Gilbert
Technik-/Wissenschafts-/F&E-Leiter bei
JW (CAYMAN) THERAPEUTICS CO. LTD
Vermögen: - $ am 31.05.2026
Profil
Mark J.
Gilbert is currently Director at Inceptor Bio LLC since 2022.
Dr. Gilbert is Chief Medical Officer at JW Therapeutics (Shanghai) Co., Ltd. since 2020.
Dr. Gilbert is Chief Medical Officer at JW (Cayman) Therapeutics Co. Ltd. Formerly, Dr. Gilbert was Senior Medical Director at Immunex Corp.
Dr. Gilbert was Independent Director at Silicon Therapeutics, Inc. from 2019 to 2021.
Dr. Gilbert was Independent Director at Indaptus Therapeutics, Inc. from 2021 to 2026.
Dr. Gilbert was Independent Director at Silicon Insite, Inc. from 2019 to 2021.
Dr. Gilbert was Vice President & Head-Global Clinical Development at Bayer Schering Pharma AG.
Dr. Gilbert was Vice President & Head-Global Clinical Development at Bayer HealthCare Pharmaceuticals, Inc. Dr. Gilbert was Vice President & Head-Global Medical Development at Berlex Pharmaceuticals, Inc. Dr. Gilbert was Executive Vice President-Research & Development at Acepodia Biotechnologies, Ltd. from 2019 to 2022.
Dr. Gilbert was Chief Medical Officer & Senior Vice President at Juno Therapeutics, Inc. from 2013 to 2020.
Education includes undergraduate degree from the University of Iowa and doctorate from the University of Iowa Carver College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.01.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Mark Gilbert
| Unternehmen | Position | Beginn |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Technik-/Wissenschafts-/F&E-Leiter | - |
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | 01.11.2022 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
Ehemalige bekannte Positionen von Mark Gilbert
| Unternehmen | Position | Ende |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 26.02.2026 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Direktor/Vorstandsmitglied | 01.05.2021 |
Silicon Therapeutics, Inc. | Direktor/Vorstandsmitglied | 01.05.2021 |
| JUNO THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ausbildung von Mark Gilbert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Manufactures, markets, and researches therapeutic products | Health Technology |
Bayer Schering Pharma AG
 Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Berlex Pharmaceuticals, Inc. | |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
University of Iowa Carver College of Medicine
 University of Iowa Carver College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Develops novel, targeted, allogeneic cell therapies to treat cancers | Health Technology |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Indaptus Therapeutics, Inc.
 Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Silicon Therapeutics, Inc. |
